The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Condition: Thyroid Cancer Interventions: Drug: Thyrogen; Radiation: I-131; Radiation: I-124 Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Diabetes | Endocrinology | Thyroid | Thyroid Cancer | Urology & Nephrology